Report: Achieving launch excellence in the challenging healthcare markets of today
|10th December 2018
Healthcare markets are becoming more competitive and complex. The sheer number of products coming off patent in the next five years, coupled with the growing healthcare spend and the number of players entering the healthcare space, mean it's clear pharma launches are becoming more challenging.
Adding to the pressure is the evolving networks of stakeholders who each have a differing needs and pain points and often communicate using novel digital channels.
However, while the market can seem overwhelming, these challenges provide pharma organisations with an opportunity to meet the unmet needs of customers through clearer and more targeted marketing, and more streamlined launches.
This in-depth report was created in collaboration with Pharma Intelligence and is based on our significant experience in this area. It features interviews with senior leaders and primary market research, as well as giving key recommendations for achieving launch success in challenging markets.
Download the white paper to learn:
- The characteristics of launch excellence evidenced by successful launches from the last two years
- How to transform the operating model to ensure market responsiveness
- How you can re-focus your brand planning to maximise success.
In the precision medicine era, the line between products and services is blurred
|27th August 2020
Precision and personalised medicines are more than products, they are services in their own right. So, how should pharma approach this uncharted territory to ensure targeted therapies work for patients?
Understanding COVID-19 and varying responses across the globe
|28th July 2020
At the beginning of the COVID-19 Pandemic, Senior Account Executive Lauren Fernandes took a course at the London School of Hygiene and Tropical Medicine to better understand how the global response to the virus and to ensure we were best positioned to serve our clients during this challenging time. She shares the key learnings and why understanding the epidemiology of the disease is integral for fighting it.
Delivering impactful customer engagements in COVID-19
|14th July 2020
Blue Latitude Health, and our parent company Fishawack Health, have developed exclusive intellectual property, processes and tools to ensure you’re engaging customers in the right way. View our service one-pagers below to find out how we can help solve your challenges whether you’re in a medical, brand, portfolio or an above brand role.